In AD, oxidized species in brain tissues increase owing to the impaired activity of glutathione S-transferase, resulting in decreased levels of SAM and increased levels of its hydrolysis product S-adenosylhomocysteine (SAHC), which inhibits SAM utilization [123]. Here, HPGDS is linked to Alzheimer disease.